This article was originally published on TipRanks.com.
Novartis (NVS) has launched a new innovation hub, Novartis Biome sub-Saharan Africa (SSA), to improve healthcare in the region by developing innovative business …
China-based biopharmaceutical firm BeiGene (BGNE) has received approval for its anti-PD-1 antibody tislelizumab from the China National Medical Products Administration (NMPA) for the …
Novartis Ag (NVS) announced that together with Molecular Partners it has begun clinical trial EMPATHY. The EMPATHY trial is a Phase 2 and …
Swiss drugmaker Novartis announced the acquisition of ocular gene therapy company Vedere Bio for a total consideration of $280 million. Under the terms …
Novartis AG announced on Saturday that its investigational spartalizumab immunotherapy drug combined with Tafinlar and Mekinist therapies failed to meet its primary endpoint …
Novartis AG (NVS) announced Thursday that its Sandoz division will sell 15 generic drugs to treat COVID-19 symptoms at zero-profit to governments in …
The U.S.
Swiss drugmaker Novartis AG (NVS) announced on Monday that it reached an agreement with U.S.
Swiss drugmaker Novartis AG (NVS) said Monday it has acquired U.S.